4ꢁ-C-Azidomethyl-β-D-Ribofuranosyl Purine and Pyrimidine
449
subanalysis by race/ethnicity, weight and HCV genotype. The 59th Annual Meeting of the American
Association for the Study of Liver Diseases (AASLD), San Francisco, California, USA, October 31-
November 4, 2008, Abstract 1899. b) Gane, E.J.; Rodriguez-Torres, M.; Nelson, D.R.; Jacobson, I.M.;
et al. Antiviral activity of the HCV nucleoside polymerase inhibitor R7128 in HCV genotype 2 and
3 prior non-responders: results of R7128 1500 mg BID with Peg-INF and ribavirine for 28 days. The
59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San
Francisco, California, USA, October 31-November 4, 2008, Abstract LB10.
9. a) Pockros, P.J.; Nelson, D.; Godofsky, E.; Rodriguez-Torres, M.; Everson, G.T.; et al. R1626 plus
Peginterferon alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral
synergy in combination with ribavirin. Hepatology 2008, 48, 385–397. b) Roberts, S.K.; Cooksley, G.;
Dore, G.J.; Robson, R.; Shaw, D.; et al. Hepatology 2008, 48, 398–406. c) Toniutto, P.; Fabris, C.;
Bitetto, D.; Fumolo, E.; Fornasiere, E.; Pirisi, M. R-1626, a specific oral NS5B polymerase inhibitor
of hepatitis C virus. IDRUGS 2008, 11, 738–749.
10. Clark, J.L.; Hollecker, L.; Mason, J.C.; Stuyver, L.J.; Tharnish, P.M.; et al. Design, synthesis, and
antiviral activity of 2ꢁ-deoxy-2ꢁ-fluoro-2ꢁ-C-methylcytidine, a potent inhibitor of hepatitis C virus
replication. J. Med. Chem. 2005, 48, 5504–5508.
11. a) Klumpp, K.; Le´veˆque, V.; Le Pogam, S.; Ma, H.; Jiang, W.-R.; et al. The novel nucleoside analog
R1479 (4ꢁ-azidocytidine) is a potent inhibitor of NS5B-dependant RNA synthesis and hepatitis
C virus replication in cell culture. J. Biol. Chem. 2006, 281, 3793–3799. b) Smith, D.B.; Martin,
J.A.; Klumpp, K.; Baker, S. J.; Blomgren, P.A.; et al. Design, synthesis, and antiviral properties of
4ꢁ-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479.
Bioorg. Med. Chem. Lett. 2007, 17, 2570–2576.
12. a) Gosselin, G.; Imbach, J.-L.; Sommadossi, J.-P. Methods and compositions for treating hepatitis
C virus using 4ꢁ-modified nucleosides. Patent WO2003026589, 2003 (173 pages). b) Griffon, J.-F.;
Dukhan, D.; Pierra, C.; Benzaria, S.; Loi, A.G.; et al. 4ꢁ-C-Methyl-β-D-ribofuranosyl purine and
pyrimidine nucleosides revisited. Nucleosides, Nucleotides Nucleic Acids 2003, 22, 707–709.
13. Baker, B.R. Stereochemistry of nucleoside synthesis, in The Ciba Foundation Symposium on the Chemistry
and Biology of the Purines, eds. G.E. Wolstenholme and C.M. O’Connor, Churchill, London, 1957, pp.
120–130.
14. Gunic, E.; Girardet, J.-L.; Pietrzkowski, Z.; Esler, C.; Wang, G. Synthesis and cytotoxicity of 4ꢁ-C- and
5ꢁ-C-substituted toyocamycins. Bioorg. Med. Chem. 2001, 9, 163–170.
15. a) Schaffer, R.; Isbell, H.S. Structure of 5-aldo-1,2-O-isopropylidene-D-xylo-pentofuranose. J. Am.
Chem. Soc. 1957, 79, 3864–3866. b) Schaffer, R. Branched-chain higher sugars. III. A 4-C-
(hydroxymethyl)-pentose. J. Am. Chem. Soc. 1959, 81, 5452–5454. c) Leonard, N.J.; Carraway, K.L.
5-Amino-5-deoxyribose derivatives. Synthesis and use in the preparation of reversed nucleosides.
J. Heterocyc. Chem. 1966, 3, 485–489. d) Jones, G.H.; Moffatt, J.G. Oxidation of carbohydrates
by the sulfoxide-carbodiimide and related methods. Oxidation with dicyclohexylcarbodiimide-
DMSO, diisopropylcarbodiimide-DMSO, acetic anhydride-DMSO, and phosphorus pentaoxide-
DMSO (dimethyl sulfoxide). Methods in Carbohydrate Chemistry 1972, 6, 315–322. e) Youssefyeh, R.D.;
Verheyden, J.P.H.; Moffatt, J.G. 4ꢁ-Substituted nucleosides. 4. Synthesis of some 4ꢁ-hydroxymethyl
nucleosides. J. Org. Chem. 1979, 44, 1301–1309. f) Jones, G.H.; Taniguchi, M.; Tegg, D.; Moffatt, J.G.
4ꢁ-Substituted nucleosides. 5. Hydroxymethylation of nucleoside 5ꢁ-aldehydes. J. Org. Chem. 1979, 44,
1309–1317.
16. a) Vorbru¨ggen, H.; Krolikiewicz, K.; Bennua, B. Nucleoside syntheses. XXII. Nucleoside synthesis
with trimethylsilyl triflate and perchlorate as catalysts. Chemische Berichte 1981, 114, 1234–1255.
b) Vorbru¨ggen, H.; Hoefle, G. Nucleoside syntheses. XXIII. On the mechanism of nucleoside
synthesis. Chemische Berichte 1981, 114, 1256–1268.
17. Saneyoshi, M.; Satoh, E. Synthetic nucleosides and nucleotides. XIII. Stannic chloride catalyzed
ribosylation of several 6-substituted purines. Chem. Pharma. Bull. 1979, 27, 2518–2521.
18. Chu, C.K.; Ma, L.; Olgen, S.; Pierra, C.; Du, J.; et al. Synthesis and antiviral activity of oxaselenolane
nucleosides. J. Med. Chem. 2000, 43, 3906–3912.